Targeting the tumor microenvironment with mesenchymal stem cells based delivery approach for efficient delivery of anticancer agents: An updated review
Authors:
- 31 December 2024
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 232, 116725
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis TherapySmall, 2022
- Mesenchymal Stem Cells for Neurological DisordersAdvanced Science, 2021
- Polysaccharide–Peptide Conjugates: A Versatile Material Platform for Biomedical ApplicationsAdvanced Functional Materials, 2020
- Engineering Stem Cell Derived Biomimetic Vesicles for Versatility and Effective Targeted DeliveryAdvanced Functional Materials, 2020
- Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?Stem Cells Translational Medicine, 2019
- Visualizing the Fate of Intra‐Articular Injected Mesenchymal Stem Cells In Vivo in the Second Near‐Infrared Window for the Effective Treatment of Supraspinatus Tendon TearsAdvanced Science, 2019
- In search of definitions: Cancer‐associated fibroblasts and their markersInternational Journal of Cancer, 2019
- Extracellular matrix (ECM) stiffness and degradation as cancer driversJournal of Cellular Biochemistry, 2018
- Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the PromiseStem Cells Translational Medicine, 2018
- Tumor microenvironment: The role of the tumor stroma in cancerJournal of Cellular Biochemistry, 2007